Hypnosis for attention problems and tiredness after stroke, brain injury or multiple sclerosis
Tests hypnosis alongside usual care in adults with stroke, brain injury or multiple sclerosis.
Plain-language title generated from the registry record
Registry title: Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis)
Key facts
- Where
- Lucerne, SwitzerlandSee the site
Where in Switzerland
- Luzerner KantonsspitalLucerne, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Luzerner Kantonsspital
- Trial code
- NCT07256704
- Record updated
- 14 August 2026
- Original description
This feasibility study investigates the potential of hypnosis as a complementary therapy for improving attentional deficits and reducing fatigue in patients with neurological conditions such as stroke, traumatic brain injury (TBI), and multiple sclerosis (MS). These patients often experience reduced spontaneous visual exploration and impaired functional independence despite current rehabilitation approaches. By integrating hypnosis with standard care and using EEG to monitor brain activity during hypnosis and sham-hypnosis sessions, this trial aims to evaluate the feasibility, acceptability, and preliminary efficacy of hypnosis in enhancing attention and reducing fatigue.Read full original descriptionShow less
Hypnosis and Attention in Patients With a Neurological Disease
This feasibility study investigates the potential of hypnosis as a complementary therapy for improving attentional deficits and reducing fatigue in patients with neurological conditions such as stroke, traumatic brain injury (TBI), and multiple sclerosis (MS). These patients often experience reduced spontaneous visual exploration and impaired functional independence despite current rehabilitation approaches. By integrating hypnosis with standard care and using EEG to monitor brain activity during hypnosis and sham-hypnosis sessions, this trial aims to evaluate the feasibility, acceptability, and preliminary efficacy of hypnosis in enhancing attention and reducing fatigue.
Inclusion: ICD-10 Diagnosis of stroke, TBI or MS; Admitted to the inpatient and/or outpatient in the Clinic for Neurology and Neurorehabilitation; Age 18 years old or older; Understanding the German language; Written informed consent.
Exclusion: Psychiatric disease; Scalp or skin conditions that interfere with EEG electrode placement (e.g. open wounds, infections, severe psoriasis) Implanted medical or neurostimulation devices that interfere with EEG electrode placement (e.g. deep brain stimulators, cochlear implants).